Ardelyx revises IBSRELA guidance, pulls XPHOZAH long-term outlook amid payor hurdles
Ardelyx reported Q2 2026 revenue growth but cited increased payor utilization management as it updates full-year and long-term projections.
SEC filing
Latest
1 story